摘要
恶性肿瘤是威胁人类生命的重大疾病之一。抗癌药物在恶性肿瘤治疗方面发挥着重要作用,特别是新型靶向治疗药物的诞生,给很多过去"被判死刑"的恶性肿瘤患者带来了生的希望,提高了生存质量,部分患者还可能实现正常寿命。但新型抗癌药物通常价格昂贵,大多数尚未纳入我国的公共保障体系,药物可及性受到很大限制。本文梳理了我国癌症患者高值抗癌药物的可及性现状,分析了影响其可及性的因素,为提高我国高值抗癌药物可及性提出政策建议。
Malignant tumors are the ma）or diseases which threat human beings. Anti-cancer medicines play important roles in the treatment of malignant tumors, especially for the new targeted therapies. They bring the life hope for cancer patients who were sentenced to death, and improve quality of life, and some patients may achieve normal lifetime. However, the new anti-cancer medicines are usually too expensive to afford, and most of them have not yet been included in Chinese public health security system, the accessibility of the new anti-cancer medicines is seriously limited. This paper introduces the accessibility of high-cost anti-cancer medicines in China, analyzes the influence factors, and proposes policy recommendations to improve the accessibility of high-cost anti-cancer medicines in China.
作者
周艳萍
王海港
胡庆河
周润奭
程丽珊
亢奋恒
孙静
ZHOU Yanping WANG Haigang HU Qinghe ZHOU Runshi CHENG Lishan KANG Fenheng SUN Jing(Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, P.R.China Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100730, P.R.China Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, 610052, P.R.China National lnstitute of Geriatrics, Beijing Hospital, Beijing, 100730, P.R.China School of Public Health, Chinese Academy of Medical Sciences ＆ Peking Union Medical College, Beijing, 100730, P.R.China)
出处
《中国循证医学杂志》
CSCD
2017年第7期862-868,共7页
Chinese Journal of Evidence-based Medicine
关键词
恶性肿瘤
高值抗癌药物
可及性
影响因素
Malignant tumor
High-cost anti-cancer medicines
Accessibility
Influence factors
